Targets,
Journal Year:
2024,
Volume and Issue:
2(1), P. 52 - 63
Published: Feb. 16, 2024
Hepatocellular
carcinoma
is
a
pressing
global
health
issue,
ranking
as
the
third
leading
cause
of
cancer-related
mortality
in
humans.
Chronic
liver
diseases,
such
hepatitis
B
and
C
infections
cirrhosis,
are
often
associated
with
hepatocellular
carcinoma,
necessitating
ongoing
research
for
improved
diagnostic
therapeutic
strategies.
Animal
models,
including
both
spontaneous
chemically
induced
models
like
diethylnitrosamine,
play
pivotal
role
understanding
mechanisms.
Metabolic
alterations
tumoral
hepatocytes
contribute
significantly
to
cancer
initiation
progression,
impacting
energy
metabolism
cell
survival.
Lectins,
specifically
Concanavalin
A,
provide
valuable
insights
into
altered
glycosylation
patterns
cells.
This
study
employs
lectin
histochemistry
assess
hepatic
A
expression
murine
model
diethylnitrosamine-induced
carcinoma.
Utilizing
confocal
laser
scanning
microscopy,
our
unveils
notable
changes
subcellular
localization
intensity
distribution
compared
healthy
tissue.
significant
increase
labeling
within
cells
shifting
perinuclear
space
observed.
These
findings
offer
molecular
providing
potential
avenues
advancements.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 14, 2025
Metabolic
reprogramming
is
one
of
the
major
biological
features
malignant
tumors,
playing
a
crucial
role
in
initiation
and
progression
cancer.
The
tumor
microenvironment
consists
various
non-cancer
cells,
such
as
hepatic
stellate
cancer-associated
fibroblasts
(CAFs),
immune
well
extracellular
matrix
soluble
substances.
In
liver
cancer,
metabolic
not
only
affects
its
own
growth
survival
but
also
interacts
with
other
cells
by
influencing
expression
release
metabolites
cytokines
(such
lactate,
PGE2,
arginine).
This
interaction
leads
to
acidification
restricts
uptake
nutrients
resulting
competition
symbiosis.
At
same
time,
neighboring
during
proliferation
differentiation
processes
impacts
immunity.
article
provides
comprehensive
overview
crosstalk
between
cancer
their
microenvironment,
deepening
our
understanding
relevant
findings
pathways.
contributes
further
regulation
development
evasion
mechanisms
while
providing
assistance
advancing
personalized
therapies
targeting
pathways
for
anti-cancer
treatment.
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 18, 2025
Amino
acid
metabolism
(AAM)
reprogramming
plays
a
crucial
role
in
hepatocellular
carcinoma
(HCC),
but
its
genetic
pathophysiology
was
not
fully
elucidated.
Therefore,
we
employed
summary
data-based
Mendelian
randomization
(SMR)
approach
to
identify
putative
causal
effects
of
the
AAM-related
genes
on
hepatitis
B
virus
(HBV)-HCC
survival
via
integrating
multi-omics
data.
Multivariate
Cox
proportional
hazards
regression
models
were
used
evaluate
associations
between
variants
and
overall
(OS)
HBV-HCC
patients
(n
=
866).
Next,
developed
pathway-specific
risk
score
(GRS)
comprising
AAM
pathway.
Subsequently,
SNPs
prioritized
using
SMR
by
OS
data
with
expression
quantitative
trait
loci
(eQTLs)
DNA
methylation
QTLs
(mQTLs)
from
blood,
as
well
eQTLs
liver
tissues.
We
identified
23
independent
associated
OS,
GRS
derived
significant
predictor
OS.
The
addition
significantly
improved
predictive
performance
5-year
model
(AUC
increased
72.04%
84.67%,
P
<
0.001).
By
mQTLs
variant
rs2074038
across
ACCS
expression,
methylation.
Furthermore,
integration
eQTL
revealed
that
levels
worse
Mechanistically,
bioinformatics
annotation
luciferase
reporter
assays
further
demonstrated
contributes
progression
allele-specific
regulation
expression.
This
study
novel
functional
SNP
poor
survival,
likely
mediated
These
findings
suggest
is
potential
therapeutic
target
highlight
need
for
validation
clinical
settings.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(5), P. 844 - 844
Published: Feb. 28, 2025
Metabolic
disorders
and
chronic
liver
disease
(CLD)
play
crucial
roles
in
the
development
progression
of
cancer
(LC).
Since
ethnic
minority
population
increasingly
suffers
from
CLD
LC,
it
is
vital
to
understand
biosocial
factors
contributing
LC.
The
'All
Us'
database,
with
significant
participation
populations,
provides
a
valuable
tool
for
studies
different
racial/ethnic
groups.
Using
databases,
including
'The
Cancer
Genome
Atlas',
this
study
aimed
data,
confounding
like
lack
immunization,
comorbidities,
socioeconomic
status
(SES)
barriers
were
analyzed
cohort
33767
[non-alcoholic
fatty
disease,
alcoholic
Hepatitis
B
C]
patients.
Among
556
LC
patients
92%
had
CLD.
hypoxanthine
known
be
increased
urine
patients,
purine
metabolic
pathway
genes
using
databases
validated
publicly
available
RNASeq
data.
We
identified
several
associated
Hispanic
(HA)
African
American
(AA)
populations
compared
non-Hispanic
White
(NHW)
populations.
HA
AA
suffer
high
SES
barriers.
While
most
related
upregulated
xanthine
dehydrogenase
(XDH),
which
converts
uric
acid,
showed
downregulation
tumor
normal
tissues.
TCGA
data
among
groups
that
only
Asian
(AN)
tumors
XDH
expression
was
significantly
lower
NHW.
decreased
mRNA
AN
benign
tissues
further
RNAseq
datasets.
Survival
analysis
confirmed
poor
overall
survival
their
tumors.
Our
population.
This
also
as
critical
alteration
has
clinical
significance
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 9, 2025
Hepatocellular
carcinoma
(HCC)
is
the
main
phenotype
of
liver
cancer
with
a
poor
prognosis.
Copper
vital
in
function,
and
HCC
cells
rely
on
it
for
growth
metastasis,
leading
to
cuproplasia.
Excessive
copper
can
induce
cell
death,
termed
cuproptosis.
Tumor
microenvironment
(TME)
pivotal
HCC,
especially
immunotherapy,
closely
related
TME
pathogenesis.
However,
how
these
two
mechanisms
contribute
intriguing.
We
conducted
latest
progress
literature
cuproplasia
cuproptosis
summarized
their
specific
roles
treatment
strategies.
The
relationship
role
have
been
deeply
summarized.
Cuproplasia
fosters
formation,
angiogenesis,
whereas
may
alleviate
mitochondrial
dysfunction
hypoxic
conditions
TME.
Inhibiting
enhancing
are
essential
achieving
therapeutic
efficacy
HCC.
An
in-depth
analysis
within
unveils
opposing
nature
impact
regulation.
Grasping
equilibrium
between
factors
crucial
deeper
understanding
shed
light
novel
directions
treating
OncoImmunology,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: April 24, 2025
Glutamate
is
well-known
as
metabolite
for
maintaining
the
energy
and
redox
homeostasis
in
cancer,
moreover
it
also
primary
excitatory
neurotransmitter
central
nervous
system.
However,
whether
glutamatergic
signaling
can
regulate
hepatocellular
carcinoma
(HCC)
progression
specific
regulatory
mechanisms
are
unknown.
In
present
study,
we
found
that
glutamate
its
receptor
NMDAR2B
were
significantly
elevated
HCC
patients,
which
predicts
poor
prognosis.
could
upregulate
CCL2
expression
on
hepatoma
cells
further
enhance
capability
of
tumor
to
recruit
tumor-associated
macrophages
(TAMs).
Mechanistically,
facilitate
through
NMDAR
pathway
by
decreasing
EZH2,
regulates
H3K27me3
levels
promoter,
rather
than
affecting
DNA
methylation.
Moreover,
inhibiting
with
MK801
delay
growth,
reduced
TAMs
implanted
Hepa1-6
mouse
models.
Our
work
suggested
induce
promote
TAM
infiltration
negatively
regulating
EZH2
cells,
might
serve
a
potential
prognostic
marker
therapeutic
target
patients.
Helicobacter,
Journal Year:
2023,
Volume and Issue:
28(6)
Published: Oct. 23, 2023
Abstract
The
microbiota
actively
and
extensively
participates
in
the
regulation
of
human
metabolism,
playing
a
crucial
role
development
metabolic
diseases.
Helicobacter
pylori
(
H.
),
when
colonizing
gastric
epithelial
cells,
not
only
induces
local
tissue
inflammation
or
malignant
transformation
but
also
leads
to
systemic
partial
changes
host
metabolism.
These
shifts
can
be
mediated
through
direct
contact,
toxic
components,
indirect
immune
responses.
Consequently,
they
influence
various
molecular
events
that
impact
nutritional
status
iron
absorption
host.
Unraveling
intricate
diverse
interaction
links
between
metabolism
modulation
is
essential
for
understanding
pathogenesis
mechanisms
developing
targeted
treatments
related
However,
significant
challenges
persist
comprehensively
complex
association
networks
among
itself,
infected
host's
status,
microbiome,
response.
Previous
metabolomics
research
has
indicated
infection
eradication
may
selectively
shape
metabolite
microbial
profiles
lesions.
Yet,
it
remains
largely
unknown
how
these
pathways,
including
isovaleric
acid,
cholesterol,
fatty
acids,
phospholipids,
specifically
modulate
carcinogenesis
affect
serum
consequently
leading
metabolic‐associated
contribution
metabolisms
still
lacks
conclusive
evidence.
In
this
review,
we
summarize
recent
advances
clinical
evidence
highlighting
associations
chronic
diseases,
as
well
its
potential
regulatory
patterns.
Technology in Cancer Research & Treatment,
Journal Year:
2023,
Volume and Issue:
22
Published: Jan. 1, 2023
Hepatocellular
carcinoma
(HCC)
is
the
primary
form
of
liver
cancer.
It
causes
∼
800
000
deaths
per
year,
which
expected
to
increase
due
increasing
rates
obesity
and
metabolic
dysfunction
associated
steatotic
disease
(MASLD).
Current
therapies
include
immune
checkpoint
inhibitors,
tyrosine
kinase
monoclonal
antibodies,
but
these
are
not
satisfactorily
effective
often
come
with
multiple
side
effects
recurrences.
Metabolic
reprogramming
plays
a
significant
role
in
HCC
progression
conserved
between
tumor
types.
Thus,
targeting
rewired
pathways
could
provide
an
attractive
option
for
cells
alone
or
conjunction
existing
treatments.
Therefore,
there
urgent
need
identify
novel
targets
involved
cancer-mediated
HCC.
In
this
review,
we
overview
molecular
rewiring
glucose
metabolism
understand
better
concepts
that
might
widen
therapeutic
window
against
deadly
Computer Methods in Biomechanics & Biomedical Engineering,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 17
Published: Dec. 14, 2024
The
prognosis
of
cancers
is
strongly
connected
with
nitrogen
metabolism
(NM),
which
plays
a
critical
role
in
the
microenvironment
and
growth
tumors.
It
unsubstantiated,
however,
how
important
NM-related
genes
are
for
hepatocellular
carcinoma
(HCC).
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Abstract
Steady
state
fluxes
are
a
measure
of
cellular
activity
under
metabolic
homoeostasis,
but
understanding
how
individual
substrates
metabolized
remains
challenge
in
large-scale
networks.
Pathway-based
approaches
such
as
elementary
flux
mode
(EFM)
analysis
limited
to
small
networks
due
the
combinatorial
explosion
pathways
and
ambiguity
decomposing
onto
EFMs.
Here,
we
present
an
alternative
approach
explain
terms
steady
flow
their
atomic
constituents.
We
refer
these
modes
(AEFMs)
show
that
computations
involving
AEFMs
orders
magnitude
faster
than
standard
Using
our
approach,
enumerate
carbon
nitrogen
five
genome-scale
models
compute
AEFM
decomposition
estimated
HepG2
liver
cancer
cell
line.
Our
results
systematically
characterize
remodelling
and,
on
network,
predict
glutamine
metabolism
through
recently
discovered
non-canonical
TCA
cycle.